Identification and Characterization of a Mucilaginibacter sp. Strain QM49 β-Glucosidase and Its Use in the Production of the Pharmaceutically Active Minor Ginsenosides (S)-Rh1 and (S)-Rg2

Applied and Environmental Microbiology

Volumn 79, Issue 19, 2013, Pages 5788-5798

  Cui, Chang Hao ^a   Liu, Qing Mei ^a,b   Kim, Jin Kwang ^a   Sung, Bong Hyun ^c   Kim, Song Gun ^c   Kim, Sun Chang ^a,b   Im, Wan Taek ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Intelligent Synthetic Biology Center   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RESIDUES; BIOTRANSFORMATION ACTIVITY; ESCHERICHIA COLI BL21; GLYCOSIDE HYDROLASES; MALTOSE BINDING PROTEINS; PROTEOLYTIC CLEAVAGE; SEQUENCE ANALYSIS; TOBACCO ETCH VIRUS;

AMINO ACIDS; ENZYMES; ESCHERICHIA COLI; PROTEINS; RHODIUM; VIRUSES;

PHARMACODYNAMICS;

AMINO ACID; BIOTRANSFORMATION; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE; HYDROLYSIS; MICROBIAL COMMUNITY; PH; PROTEIN;

BETA GLUCOSIDASE; GINSENOSIDE; HYBRID PROTEIN;

ARTICLE; BACTEROIDETES; BIOTRANSFORMATION; CHEMISTRY; CLUSTER ANALYSIS; DNA SEQUENCE; ENZYMOLOGY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MOLECULAR GENETICS; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; SEQUENCE HOMOLOGY;

BACTEROIDETES; BETA-GLUCOSIDASE; BIOTRANSFORMATION; CLUSTER ANALYSIS; ESCHERICHIA COLI; GENE EXPRESSION; GINSENOSIDES; KINETICS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; RECOMBINANT FUSION PROTEINS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY;

EID: 84884185736     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01150-13     Document Type: Article

References (64)

1. Ang-Lee MK, Moss J, Yuan CS. 2001. Herbal medicines and perioperative care. JAMA 286:208-216.
2. Hu C, Wei H, Kong H, Bouwman J, Gonzalez-Covarrubias V, van der Heijden R, Reijmers TH, Bao X, Verheij ER, Hankemeier T, Xu G, van der Greef J, Wang M. 2011. Linking biological activity with herbal constituents by systems biology-based approaches: effects of Panax ginseng in type 2 diabetic Goto-Kakizaki rats. Mol. Biosyst. 7:3094-3103.
3. Attele AS, Wu JA, Yuan CS. 1999. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol. 58:1685-1693.
4. Christensen LP. 2009. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv. Food Nutr. Res. 55:1-99.
5. Jia L, Zhao Y, Liang XJ. 2009. Current evaluation of the millennium phytomedicine- ginseng II: collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine. Curr. Med. Chem. 16:2924-2942.
6. Kim SK, Park JH. 2011. Trends in ginseng research in 2010. J. Ginseng. Res. 35:389-398.
7. Sun LQ. 2004. Information on research and application of ginseng, the king of traditional and herbal medicines. Asian J. Drug Metab. Pharmacokinet. 4:261-284.
8. Lee JH, Hyun Kim YJDH. 2011. Cloning and characterization of alpha- L-arabinofuranosidase and bifunctional alpha-L-arabinopyranosidase/beta-D-galactopyranosidase from Bifidobacterium longum H-1. J. Appl. Microbiol. 111:1097-1107.
9. 1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J. Steroid. Biochem. Mol. Biol. 84:463-468.
10. 1 possesses antiallergic and anti-inflammatory activities. Int. Arch. Allergy Immunol. 133:113-120.
11. 1 and protopanaxatriol. J. Pharmacol. Sci. 109:504-510.
12. 1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells. Eur. J. Pharmacol. 679:24-33.
13. Li GX, Liu ZQ. 2008. The protective effects of ginsenosides on human erythrocytes against hemin-induced hemolysis. Food. Chem. Toxicol. 46: 886-892.
14. Liu ZQ, Luo XY, Sun YX, Chen YP, Wang ZC. 2002. Can ginsenosides protect human erythrocytes against free-radical-induced hemolysis? Biochim. Biophys. Acta 1572:58-66.
15. Sun J, Hu S, Song X. 2007. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Vaccine 25:1114-1120.
16. Liu ZQ, Luo XY, Liu GZ, Chen YP, Wang ZC, Sun YX. 2003. In vitro study of the relationship between the structure of ginsenoside and its antioxidative or prooxidative activity in free radical induced hemolysis of human erythrocytes. J. Agric. Food. Chem. 51:2555-2558.
17. 2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. J. Ethnopharmacol. 115:441-448.
18. Choi KT. 2008. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C. A. Meyer. Acta Pharmacol. Sin. 29:1109-1118.
19. Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, He TC, Yuan CS. 2007. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med. 73:669-674.
20. Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK, Park JH. 2000. Steaming of ginseng at high temperature enhances biological activity. J. Nat. Prod. 63:1702-1704.
21. Bae EA, Han MJ, Kim EJ, Kim DH. 2004. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch. Pharm. Res. 27:61-67.
22. Yun TK, Lee YS, Lee YH, Kim SI, Yun HY. 2001. Anticarcinogenic effect of Panax ginseng CA Meyer and identification of active compounds. J. Korean Med. Sci. 16(Suppl.):S6-S18.
23. An DS, Cui CH, Lee HG, Wang L, Kim SC, Lee ST, Jin F, Yu H, Chin YW, Lee HK, Im WT, Kim SG. 2010. Identification and characterization of a novel Terrabacter ginsenosidimutans sp. nov. beta-glucosidase that transforms ginsenoside Rb1 into the rare gypenosides XVII and LXXV. Appl. Environ. Microbiol. 76:5827-5836.
24. Cui CH, Kim SC, Im WT. 2013. Characterization of the ginsenosidetransforming recombinant beta-glucosidase from Actinosynnema mirum and bioconversion of major ginsenosides into minor ginsenosides. Appl. Microbiol. Biotechnol. 97:649-659.
25. Hong H, Cui CH, Kim JK, Jin FX, Kim SC, Im WT. 2012. Enzymatic biotransformation of ginsenoside Rb1 and gypenoside XVII into ginsenosides Rd and F2 by recombinant β-glucosidase from Flavobacterium johnsoniae. J. Ginseng Res. 36:418-424.
26. 1 to minor ginsenoside F1 using novel recombinant ginsenoside hydrolyzing glycosidase cloned from Sanguibacter keddieii and enzyme characterization. J. Biotechnol. 161:294-301.
27. Kim SJ, Lee CM, Kim MY, Yeo YS, Yoon SH, Kang HC, Koo BS. 2007. Screening and characterization of an enzyme with beta-glucosidase activity from environmental DNA. J. Microbiol. Biotechnol. 17:905-912.
28. 1. Biosci. Biotechnol. Biochem. 64:2739-2743.
29. Noh KH, Son JW, Kim HJ, Oh DK. 2009. Ginsenoside compound K production from ginseng root extract by a thermostable beta-glycosidase from Sulfolobus solfataricus. Biosci. Biotechnol. Biochem. 73:316-321.
30. Quan LH, Jin Y, Wang C, Min JW, Kim YJ, Yang DC. 2012. Enzymatic transformation of the major ginsenoside Rb2 to minor compound Y and compound K by a ginsenoside-hydrolyzing beta-glycosidase from Microbacterium esteraromaticum. J. Ind. Microbiol. Biotechnol. 39:1557-1562.
31. Quan LH, Min JW, Jin Y, Wang C, Kim YJ, Yang DC. 2012. Enzymatic biotransformation of ginsenoside Rb1 to compound K by recombinant beta-glucosidase from Microbacterium esteraromaticum. J. Agric. Food. Chem. 60:3776-3781.
32. 1 by recombinant beta-glucosidase. Biotechnol. Lett. 34:913-917.
33. Wang L, Liu QM, Sung BH, An DS, Lee HG, Kim SG, Kim SC, Lee ST, Im WT. 2011. Bioconversion of ginsenosides Rb1, Rb2, Rc and Rd by novel beta-glucosidase hydrolyzing outer 3-O glycoside from Sphingomonas sp. 2F2: cloning, expression, and enzyme characterization. J. Biotechnol. 156:125-133.
34. Wan JB, Zhang QW, Ye WC, Wang YT. 2008. Quantification and separation of protopanaxatriol and protopanaxadiol type saponins from Panax notoginseng with macroporous resins. Sep. Purif. Technol. 60:198-205.
35. Zhao Y, Chen B, Yao SZ. 2007. Separation of 20(S)-protopanaxdiol typeginsenosides and 20(S)-protopanaxtriol type ginsenosides with the help of macroporous resin adsorption and microwave assisted desorption. Sep. Purif. Technol. 52:533-538.
36. Bae EA, Shin JE, Kim DH. 2005. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Biol. Pharm. Bull. 28:1903-1908.
37. 1, and F1 from protopanaxatriol-type ginseng saponin mixture. Planta Med. 69:285-286.
38. Buck JD. 1982. Nonstaining KOH method for determination of gram reactions of marine bacteria. Appl. Environ. Microbiol. 44:992-993.
39. Smibert RM, Krieg NR. 1994. Phenotypic characterization. Methods for general and molecular bacteriology, p 607-654. In Gerhardt P, Murray RGE, Wood WA, Krieg NR (ed), Methods for general and molecular microbiology. ASM Press, Washington, DC.
40. Collins MD. 1985. Analysis of isoprenoid quinones. Methods Microbiol. 18:329-366.
41. Sasser M. 1990. Identification of bacteria by gas chromatography of cellular fatty acids. Technical note 101. Microbial ID, Newark, DE.
42. Im WT, Kim SY, Liu QM, Yang JE, Lee ST, Yi TH. 2010. Nocardioides ginsengisegetis sp. nov., isolated from soil of a ginseng field. J. Microbiol. 48:623-628.
43. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
44. Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. (Oxford) 41:95-98.
45. Kimura M. 1983. The neutral theory of molecular evolution. Cambridge University Press, New York, NY.
46. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
47. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
48. Felsenstein J. 1985. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783-791.
49. Mesbah M, Premachandran U, Whitman WB. 1989. Precise measurement of the GC content of deoxyribonucleic acid by high-performance liquid chromatography. Int. J. Syst. Bacteriol. 39:159-167.
50. Cleland WW. 1979. Statistical analysis of enzyme kinetic data. Methods Enzymol. 63:103-138.
51. Riesenberg D, Menzel K, Schulz V, Schumann K, Veith G, Zuber G, Knorre WA. 1990. High cell density fermentation of recombinant Escherichia coli expressing human interferon alpha 1. Appl. Microbiol. Biotechnol. 34:77-82.
52. An DS, Cui CH, Sung BH, Yang HC, Kim SC, Lee ST, Im WT, Kim SG. 2012. Characterization of a novel ginsenoside-hydrolyzing alpha-Larabinofuranosidase, AbfA, from Rhodanobacter ginsenosidimutans Gsoil 3054T. Appl. Microbiol. Biotechnol. 94:673-682.
53. Shipkowski S, Brenchley JE. 2005. Characterization of an unusual coldactive beta-glucosidase belonging to family 3 of the glycoside hydrolases from the psychrophilic isolate Paenibacillus sp. strain C7. Appl. Environ. Microbiol. 71:4225-4232.
54. Harvey AJ, Hrmova M, De Gori Varghese NJ, Fincher GB. 2000. Comparative modeling of the three-dimensional structures of family 3 glycoside hydrolases. Proteins 41:257-269.
55. Hashimoto W, Miki H, Nankai H, Sato N, Kawai S, Murata K. 1998. Molecular cloning of two genes for beta-D-glucosidase in Bacillus sp. GL1 and identification of one as a gellan-degrading enzyme. Arch. Biochem. Biophys. 360:1-9.
56. 1 by recombinant beta-glucosidase. Molecules 14:2043-2048.
57. Quan LH, Min JW, Yang DU, Kim YJ, Yang DC. 2012. Enzymatic biotransformation of ginsenoside Rb1 to 20S-Rg3 by recombinant betaglucosidase from Microbacterium esteraromaticum. Appl. Microbiol. Biotechnol. 94:377-384.
58. Korea Food & Drug Administration (KFDA). 2011. Production record of health functional food and analysis result of that in 2011, Seoul, South Korea.
59. Chi H, Ji GE. 2005. Transformation of ginsenosides Rb1 and Re from Panax ginseng by food microorganisms. Biotechnol. Lett. 27:765-771.
60. An DS, Wang L, Kim MS, Bae HM, Lee ST, Im WT. 2011. Solirubrobacter ginsenosidimutans sp. nov, isolated from soil of a ginseng field. Int. J. Syst. Evol. Microbiol. 61:2606-2609.
61. Wang L, An DS, Kim SG, Jin FX, Kim SC, Lee ST, Im WT. 2012. Ramlibacter ginsenosidimutans sp nov, with ginsenoside-converting activity. J. Microbiol. Biotechnol. 22:311-315.
62. Shibata S, Fujita M, Itokawa H, Tanaka O, Ishii T. 1963. Studies on the constituents of Japanese and Chinese crude drugs XI. Panaxadiol, a sapogenin of ginseng roots. Chem. Pharm. Bull. Tokyo 11:759-761.
63. Shibata S, Tanaka O, Soma K, Ando T, Iida Y, Nakamura H. 1965. Studies on saponins and sapogenins of ginseng. The structure of panaxatriol. Tetrahedron Lett. 42:207-213.
64. Leung KW, Wong AS. 2010. Pharmacology of ginsenosides: a literature review. Chin. Med. 5:20-21.